Endovia Health Sciences, Inc. — Form 8-K
Filed August 28, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 45/100
What the filing says
Form 8-K filed 2026-08-28 discloses Item 3.02 (unregistered sales of equity securities) for period ending 2026-08-25. The filing document header confirms the event occurred but the actual text content—including counterparty identity, share count, price, dollar amount, and dilution percentage—is not provided in the extracted filing materials. No specifics can be determined from the available data.
Why this rating
Unregistered equity sales are routine corporate actions and disclosure items. Without dollar amount or share count, cannot assess materiality relative to $6.5M market cap. Generic filing flag only.
Extracted items
See more from August 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.